Valuation: Genmab A/S

Market Cap 128B 20.04B 17.19B 16.05B 14.73B 27.69B 1,915B 28.15B 189B 74.16B 961B 75.24B 73.61B 3,176B P/E 2026 *
27.2x
P/E 2027 * 19.2x
Enterprise Value 148B 23.1B 19.81B 18.5B 16.98B 31.92B 2,208B 32.45B 218B 85.49B 1,107B 86.73B 84.85B 3,661B EV / Sales 2026 *
5.11x
EV / Sales 2027 * 4.14x
Free-Float
95.42%
Yield 2026 *
-
Yield 2027 * -
1 day-1.21%
1 week+5.88%
Current month+15.36%
1 month+16.08%
3 months+24.47%
6 months+15.67%
Current year+5.77%
1 week 2,005
Extreme 2005
2,187
1 month 1,819.5
Extreme 1819.5
2,187
Current year 1,512
Extreme 1512
2,257
1 year 1,512
Extreme 1512
2,257
3 years 1,157
Extreme 1157
2,710
5 years 1,157
Extreme 1157
3,327
10 years 786.2
Extreme 786.2
3,327
Manager TitleAgeSince
Chief Executive Officer 65 2010-05-31
Director of Finance/CFO 48 2020-02-29
Chief Tech/Sci/R&D Officer - 2024-08-15
Director TitleAgeSince
Director/Board Member 75 2003-10-31
Director/Board Member 58 2014-12-31
Director/Board Member 75 2014-12-31
Date Insider Type Main position Quantity % Market Cap.
12/1/25 Fiscal year

Director

189 0.0003%
12/1/25 Fiscal year

Director

189 0.0003%
12/1/25 Fiscal year

Director

283 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-1.23%+5.88%+38.91%-14.07% 20.04B
-1.90%+3.12%+81.70%+110.88% 72.21B
+0.18%+16.57%+56.14%+92.81% 63.98B
-0.75%-1.22%+2.71%+501.29% 28.53B
+3.63%+8.57%+62.12%+24.72% 25.07B
-3.69%+21.98%+1.54%+2.50% 28.42B
0.00%-2.78%+247.46%+423.83% 18.19B
+1.81%+1.43%+23.67%+527.06% 15.96B
-0.81%+7.96%+44.96%+157.77% 13.48B
-1.12%+2.48%+350.20%+216.38% 12.63B
Average -0.40%+5.40%+90.94%+204.32% 29.85B
Weighted average by Cap. -0.62%+6.52%+73.23%+166.29%

Financials

2026 *2027 *
Net sales 29.01B 4.52B 3.88B 3.62B 3.32B 6.25B 432B 6.36B 42.76B 16.75B 217B 16.99B 16.62B 717B 33.71B 5.26B 4.51B 4.21B 3.86B 7.27B 502B 7.38B 49.69B 19.46B 252B 19.74B 19.31B 833B
Net income 4.93B 769M 659M 616M 565M 1.06B 73.47B 1.08B 7.26B 2.84B 36.85B 2.89B 2.82B 122B 7.13B 1.11B 954M 891M 817M 1.54B 106B 1.56B 10.51B 4.12B 53.3B 4.18B 4.08B 176B
Net Debt 19.62B 3.06B 2.63B 2.45B 2.25B 4.23B 293B 4.3B 28.92B 11.33B 147B 11.49B 11.24B 485B 11.13B 1.74B 1.49B 1.39B 1.28B 2.4B 166B 2.44B 16.41B 6.42B 83.21B 6.52B 6.38B 275B
Logo Genmab A/S
Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.4%); - income from sales of products (10.7%); - other (5.9%): primarily income from partnership agreement. Net sales are distributed geographically as follows: Denmark (89.4%), the United States (4.9%) and Japan (5.7%).
Employees
3,119
Date Price Change Volume
26-08-20 DKK 2,144.00 -0.37% 30,973
26-08-19 DKK 2,152.00 +2.28% 99,873
26-08-18 DKK 2,104.00 0.00% 108,957
26-08-17 DKK 2,104.00 +3.80% 177,078
26-08-14 DKK 2,027.00 +0.10% 102,525
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2,152.00DKK
Average target price
2,410.46DKK
Spread / Average Target
+12.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GMAB Stock